{"filings":[{"id":1984796,"accession_number":"0001493152-26-035574","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2026-07-31T15:50:06+00:00","items":["5.02","5.07"],"status":"ready","headline":"Milestone Scientific 2026 annual meeting results: board elected, share authorization increased","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders elected five incumbent directors: Casamento, Goldman, Hines, Demesmin, Sayed to serve until 2027 annual meeting.","Approved amendment to increase authorized common shares from 125M to 135M (96.59% for).","Approved amendment to 2020 Equity Incentive Plan increasing available shares from 11.5M to 28.75M (80.82% for).","Board re-elected Kelly Ulto and Greg Shilling as directors; Ulto appointed Audit Chair, Shilling Compensation Chair.","Say-on-pay approved with 83.55% support; Grassi & Co. ratified as auditors with 97.68% for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1943278,"accession_number":"0001493152-26-035264","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2026-07-29T21:28:24+00:00","items":["8.01","9.01"],"status":"ready","headline":"Directors convert $466k in bridge notes to common stock, contingent on $0.50/share price","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Holders Benedetta Casamento, Dr. Didier Demesmin, and Neal Goldman submitted conversion notices on July 24, 2026.","Remaining principal amounts: Casamento $116,495.47, Demesmin $58,247.73, Goldman $291,238.66.","Conversions become effective automatically when common stock fair value is at least $0.50 per share and holder is permitted to trade.","No shares have been issued as of the filing date; conversion is contingent on stock price condition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1259597,"accession_number":"0001493152-26-030044","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2026-06-25T13:00:15+00:00","items":["1.01","5.02","7.01","9.01"],"status":"ready","headline":"Milestone Scientific appoints two independent directors and names new Executive Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Benedetta Casamento transitions from Board Chair to Executive Chairman, receiving $75,000 annual salary and $100,000 restricted stock grant.","Kelly Ulto and Greg Shilling appointed as independent directors; Ulto chairs Audit Committee, Shilling chairs Compensation Committee.","Founder Leonard Osser enters restructured agreement reducing base compensation to $48,000/year and enters lock-up through April 20, 2027.","Director Shanth Thiyagalingam resigns, not seeking re-election, to focus on CEO role at PainTEQ."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99219,"accession_number":"0001493152-26-021512","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Milestone Scientific dismisses auditor CBIZ; engages Grassi & Co. effective May 15, 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CBIZ CPAs' 2025 audit report included a going concern explanatory paragraph about substantial doubt.","No disagreements or reportable events during 2025 or interim period through April 30, 2026.","New auditor Grassi & Co. engaged for fiscal year ending Dec 31, 2026, approved by Audit Committee.","CBIZ had become auditor in April 2025 via acquisition of Marcum LLP's attest business."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99218,"accession_number":"0001493152-26-021506","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Milestone Scientific reprices CEO & SVP options and proposes PRSU plan with up to 17.2M shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Eric Hines and SVP Jason Papes surrender options at $0.46-$0.50 for new options at $0.31 exercise price.","New options vest 500K shares immediately (accelerated from 200K) and 750K on each of next two anniversaries.","PRSU sub-plan subject to stockholder approval; aggregate pool of 17,234,635 shares if all five milestones met.","PRSU grants of 5.17M shares to Hines and 3.02M each to Harcum and Papes (total 11.2M shares).","Performance milestones: LTM net sales >$11M/$13M/$15M, market cap >$50M, qualified acquisition with >$10M revenue."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99217,"accession_number":"0001493152-26-018231","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2026-04-21T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Milestone Scientific closes $2.15M private placement of units at $0.27/unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 7,962,963 units, each consisting of one common share and one warrant (exercise $0.3375, 3-yr term).","Gross proceeds $2.15M: $1.80M cash + $0.351M conversion of director/officer bridge notes; no placement agent.","Directors and officers purchased $150K cash units and converted $351K bridge notes on same terms as investors.","Proceeds for working capital and past due payables; additional $2.69M if warrants fully exercised.","12-month lock-up agreements for directors, officers, and certain stockholders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99216,"accession_number":"0001493152-26-014892","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2026-04-02T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Milestone Scientific amends MOU with Innovest/BP4, extends lock-up deadline to April 17, 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment extends deadline for BP4 lock-up agreements to April 17, 2026, with automatic extension to May 1 if a capital raise is underway.","Qualified Offering redefined: one or more offerings within 45 days with gross proceeds of at least $900K and up to 19.99% of shares (~$2.3M at $0.29/sh).","Company agrees to pay BP4 an additional $27,500 within 5 business days for disbursements, subject to $100K aggregate cap.","Other Locked-Up Parties expanded to include directors, officers, and United Systems and its affiliates."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115101,"accession_number":"0001493152-26-009581","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2026-03-11T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Milestone Scientific increases authorized common shares from 100M to 125M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Certificate of Amendment filed with Delaware Secretary of State on March 10, 2026, effective upon filing.","Stockholders approved the increase at the December 18, 2025 annual meeting.","All other terms of the Restated Certificate of Incorporation remain unchanged.","Increase in authorized shares may be used for future financing or corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115099,"accession_number":"0001493152-26-005041","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K/A","filed_at":"2026-02-04T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"MLSS enters amended MoU locking up ~8.9M BP4 shares for 12 months post-$2.5M qualified offering","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["BP4 (controlled by Innovest) agrees to lock up ~8.9M shares of MLSS for 12 months after a Qualified Offering raising at least $2.5M.","BP4 can distribute shares early if MLSS stock exceeds $0.50, $0.70, $0.90 for 10 consecutive days (33.33% each tranche).","Other parties (directors, officers, Leonard Osser, United Systems) must also enter lock-up agreements.","Company pays up to $100k in fees, including $32k within 5 days. Standstill until Jan 31 (extendable to Feb 15).","Lock-up and MoU conditional on BP4 shareholder approval by January 25, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115100,"accession_number":"0001493152-26-002934","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2026-01-20T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"Milestone Scientific enters lock-up agreement with 11.31% shareholder BP4 after $2.5M offering","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["BP4 S.r.l., holder of 11.31% of MLSS common stock, agrees to 12-month lock-up after $2.5M offering.","Lock-up release tranches: 33.33% at $0.50, additional 33.3% at $0.70, final 33.3% at $0.90 (10 consecutive trading days).","BP4 shareholders approved the MOU on January 15, 2026.","Customary underwriter exceptions apply; distributions to BP4 shareholders permitted upon price triggers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131492,"accession_number":"0001493152-25-029067","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2025-12-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Milestone Scientific shareholders elect six directors, approve share increase to 125M, ratify auditors","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six incumbent directors re-elected with average 92.84% votes for; Benedicta Casamento got 85.92%.","Amendment to increase authorized common stock from 100M to 125M shares passed with 96.18% of votes cast.","Ratification of CBIZ CPA P.C. as independent auditors for FY 2025 approved with 98.38% of votes cast (excluding broker non-votes).","Voter turnout was 61.53% (48.38M of 78.63M outstanding shares)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131491,"accession_number":"0001493152-25-022357","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2025-11-13T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Leonard A. Osser resigns from board, remains employed and consulting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Leonard A. Osser resigned as director effective November 7, 2025.","Osser will continue involvement via employment agreement and consulting with U.S. Asian Consulting Group, LLC.","No immediate replacement for board seat disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131490,"accession_number":"0001493152-25-017919","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2025-10-14T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Milestone Scientific receives NYSE American delisting notice for non-compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received NYSE American letter on Oct 8, 2025, citing non-compliance with Sections 1003(a)(ii) and (iii) of the Company Guide.","Must submit a plan of compliance by November 7, 2025, to regain listing.","If plan accepted, company remains listed subject to periodic review; if not, delisting procedures may begin.","Failure to comply by April 8, 2027, or lack of progress will trigger delisting.","Management is pursuing options and intends to submit compliance plan by deadline."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148079,"accession_number":"0001437749-25-024900","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Milestone Scientific appoints Eric Hines as CEO; compensation includes options for 2M shares","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Eric Hines named President and CEO effective July 31, 2025; also appointed to the Board.","Base salary $15K/month through Dec 2025, then $25K/month starting Jan 2026 if employment continues.","Signing bonus options for 2,000,000 shares; 10% vest immediately, 90% in three equal annual installments.","Hines previously President of North America at Ex Libris, scaling revenue from ~$50M to over $100M.","Press release cites recent Medicare Part B payment rate assignments and commercial insurance reimbursements for CompuFlo."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.62,"calibrated_materiality_score":0.62,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166827,"accession_number":"0001437749-25-017562","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2025-05-19T23:59:59+00:00","items":["5.02","7.01"],"status":"ready","headline":"Milestone Scientific appoints Shanth Thiyagalingam as independent director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed on May 14, 2025 as an independent director; fills Board vacancy.","Thiyagalingam is CEO of PainTEQ, a medical device maker, with prior roles at Abbott, Nevro, Stryker, and St. Jude Medical.","Brings medical device industry and commercial leadership experience to the Board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166826,"accession_number":"0001437749-25-012685","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2025-04-22T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Milestone Scientific replaces auditor Marcum LLP with CBIZ CPAs P.C.","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Marcum LLP resigned effective April 22, 2025; CBIZ CPAs P.C. engaged for FY ending Dec 31, 2025.","Marcum's reports on FY2023 and FY2024 financials contained no adverse opinion or modification.","No disagreements or reportable events occurred during FY2023, FY2024, or subsequent interim period.","Company did not consult CBIZ on accounting principles, audit opinions, or reportable matters before engagement.","Marcum provided a letter to SEC (Exhibit 16.1) agreeing with the disclosures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184231,"accession_number":"0001437749-25-000987","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2025-01-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Giandomenico Trombetta resigns from Milestone Scientific board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Giandomenico Trombetta resigned as director effective January 12, 2025, citing personal reasons and immediate matters.","Trombetta confirmed no disagreement with the company's operations, finances, policies, or practices.","No replacement has been announced; board size reduced by one member."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200828,"accession_number":"0001437749-24-038111","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2024-12-20T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Milestone Scientific finalizes consulting agreement with ex-CEO Arjan Haverhals","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Consulting agreement with RH Consulting LLC effective Jan 1, 2025, for indefinite term.","Annual fee of $350,000: $150,000 in Q1 2025, then $66,666 per quarter thereafter.","Services include sales/business strategy, reimbursement, distributor management, and R&D guidance.","No minimum time commitment; either party may terminate with 90 days' notice.","Haverhals remains a director and retains rights under expiring employment agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200827,"accession_number":"0001437749-24-035286","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2024-11-14T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Milestone Scientific CEO Arjan Haverhals to retire Dec 31, 2024; Chairman Neal Goldman named interim CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Arjan Haverhals retires as officer on Dec 31, 2024; remains director and consultant through family company.","Chairman Neal Goldman appointed Interim CEO effective January 1, 2025; board to engage executive search for permanent CEO.","Haverhals receives modified 2024 bonus (50% cash, 50% stock vs prior 33%/67%) and $350k consulting fee for 2025.","Press release highlights recent Medicare payment rate granted for CompuFlo Epidural System under CPT code 0777T.","Haverhals says retirement not due to any disagreement with board or management."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216827,"accession_number":"0001437749-24-030130","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2024-09-27T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Milestone Scientific posts investor presentation on Sep 27; details not in filing","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Investor presentation made available on company website on September 27, 2024.","Presentation is furnished as Exhibit 99.1, but no text content is provided in this 8-K.","No new financial guidance, operational metrics, or strategic changes disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216826,"accession_number":"0001437749-24-022982","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2024-07-18T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Milestone Scientific annual meeting elects all directors, ratifies auditors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All seven incumbent directors elected with at least 30 million shares for each; broker non-votes 20.4 million on each.","Ratification of Marcum LLP as auditors approved: 51.1M for, 0.28M against, 20k abstentions.","51.4 million shares voted (66.54% of 77.2 million outstanding).","Meeting held July 16, 2024; results reported July 18, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236556,"accession_number":"0001437749-24-011488","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2024-04-09T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"Milestone Scientific nets $1.98M from selling NOLs and R&D credits to Comcast","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Received net $1,983,095 from Comcast Corporation on April 8, 2024 for unused NOLs and R&D tax credits.","Funds used for general corporate purposes and working capital; must spend only on NJ Program allowable expenses.","Company must maintain NJ headquarters for 5 years and file quarterly reports with the State of New Jersey.","Up to face value of tax credits subject to recapture if Company breaches NJ office or use-of-funds obligations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254195,"accession_number":"0001437749-24-001289","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2024-01-12T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Milestone Scientific underwriter exercises overallotment, raising $216,847","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Maxim Group exercised overallotment for 372,110 shares at $0.63 per share on Jan 12, 2024.","Net proceeds to Milestone Scientific after underwriting discounts and commissions: $216,847.","Shares sold to underwriter at 7.5% discount to $0.63 public offering price.","Overallotment is part of December 10, 2023, public offering of 4,765,000 shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":271671,"accession_number":"0001437749-23-034235","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2023-12-12T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Milestone Scientific prices $3M public offering of 4.765M shares at $0.63 per share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering of 4,765,000 common shares at $0.63/share; gross proceeds ~$3.0 million.","Underwriter granted 45-day option to purchase up to 714,750 additional shares for over-allotments.","Net proceeds after discounts and expenses ~$2.56 million; expected closing Dec 13, 2023.","Officers and directors subject to 120-day lockup; company restricted from price-reset securities for 180 days."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":288528,"accession_number":"0001437749-23-025653","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2023-09-12T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Milestone Scientific appoints Dr. Didier Demesmin as independent director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed September 6, 2023 as independent director by unanimous board vote.","Dr. Demesmin is CEO/Medical Director of University Pain Medicine Center since 2007.","Director of Pain Management at St. Peter's University Hospital since 2006.","Holds clinical faculty positions at Rutgers RWJ Medical School and several hospital pain medicine departments.","Earned MD from UMDNJ and MBA from Northwestern Kellogg in 2018."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":288527,"accession_number":"0001437749-23-024620","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2023-08-24T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Milestone Scientific CFO Peter J. Milligan resigns effective Sept 1, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Peter J. Milligan resigns effective September 1, 2023, citing decision to pursue other opportunities.","Company has initiated search for a successor; no replacement has been named as of filing date.","Current financial and accounting team expected to support ongoing operations and reporting in interim."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":288526,"accession_number":"0001437749-23-019843","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2023-07-13T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Milestone Scientific amends CEO Arjan Haverhals' agreement; severance extended from 6 months to 2 years","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment extends severance period for CEO Arjan Haverhals from six months to two years upon qualifying termination.","Change applies to continued Base Compensation and certain other benefits, subject to standard payroll and withholding.","All other terms of the employment agreement remain unchanged; amendment recommended by Compensation Committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":309062,"accession_number":"0001437749-23-019021","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2023-06-30T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Milestone Scientific shareholders elect directors, approve equity plan increase, ratify auditor at 2023 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six incumbent directors re-elected: Neal Goldman 15.3M for, Leonard Osser 14.96M for, others similarly.","Amendment to 2020 Equity Incentive Plan approved, increasing authorized shares from 4M to 11.5M (13.6M for, 4.4M against).","Marcum LLP ratified as independent auditor for FY2023 with 35M for, 122K against.","Broker non-votes of 17M on director elections and equity plan due to discretionary voting limits."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327820,"accession_number":"0001437749-23-002584","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2023-02-06T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Milestone Scientific appoints Peter Milligan as part-time CFO effective Feb 1, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Annual salary of $120,000 plus incentive bonus target of 40% of cash compensation payable in shares.","Eligible for $100,000 in annual restricted stock ($50k Feb 1, $50k Aug 1) valued at closing price, issued 60 days post-termination.","Milligan previously CFO at Melinta Therapeutics (led through Chapter 11), Exelis, and senior finance roles at ITT and AT&T."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327819,"accession_number":"0001437749-23-000400","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2023-01-05T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Leslie Bernhard resigns; Neal Goldman named Chairman; CEO Arjan Haverhals joins board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Leslie Bernhard resigned as director, Audit Committee Chair, and Board Chair after 20 years; no disagreement cited.","Board appointed Neal Goldman (director since 2019) as Chairman of the Board.","CEO Arjan Haverhals appointed to the Board; he also serves as President and CEO since 2021/2020.","Audit Committee: Benedetta Casamento (Chair, financial expert), Neal Goldman, Michael McGeehan.","Compensation Committee: Michael McGeehan (Chair), Neal Goldman, Benedetta Casamento; Nom/Gov: Casamento (Chair), Leonard Osser, McGeehan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345498,"accession_number":"0001437749-22-028646","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2022-12-07T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Leonard M. Schiller resigns from Milestone Scientific board after 26 years","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Leonard M. Schiller resigned as director on December 5, 2022.","Resignation was not due to any disagreement with the company.","Schiller served approximately 26 years on the Board, the company expressed thanks.","No replacement has been announced at this time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345497,"accession_number":"0001437749-22-024334","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2022-10-18T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Milestone Scientific dismisses Friedman LLP, appoints Marcum as auditor after merger","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Audit committee approved dismissal of Friedman LLP and engagement of Marcum LLP effective October 13, 2022.","Friedman merged with Marcum effective September 1, 2022; services now provided by Marcum.","No disagreements or reportable events with Friedman in fiscal years 2020 and 2021 or subsequent interim period.","Friedman's audit reports for 2020 and 2021 contained no adverse opinion or qualification.","Friedman furnished a letter to the SEC agreeing with the disclosures, attached as Exhibit 16.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":381406,"accession_number":"0001437749-22-014968","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2022-06-14T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Milestone Scientific stockholders elect seven directors and approve executive compensation and auditor at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All seven incumbent directors elected; votes for ranged from 27.6M to 28.2M; broker non-votes ~18.1M each.","Non-binding advisory 'say-on-pay' resolution approved: 27,561,295 for, 869,649 against, 196,125 abstaining.","Ratification of Friedman LLP as auditors for FY2022: 46,579,477 for, 55,345 against, 52,220 abstaining."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":381405,"accession_number":"0001437749-22-010581","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2022-05-03T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Milestone Scientific appoints Benedetta Casamento to Board of Directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Benedetta Casamento appointed to the Board effective April 27, 2022.","Casamento also serves on the Board of Charles & Colvard, Ltd. since May 2017.","Her background includes CEO of Calypso St. Barth and EVP at The Talbots, Inc.","Casamento previously held leadership roles at Liz Claiborne Inc. and Saks Fifth Avenue.","She also served as Chairman and President of AI company Allyke, Inc. in 2016-2017."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":399395,"accession_number":"0001437749-22-001292","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2022-01-20T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Milestone Scientific reports >$14M cash at end of 2021, liquidity for 2 years","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Cash and equivalents exceeded $14M at Dec 31, 2021, equivalent to year-end 2020.","CEO Arjan Haverhals stated sufficient liquidity to fund operations for 2 more years.","Disclosure made during Jan 20, 2022 fireside chat with Maxim Group."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":418386,"accession_number":"0001437749-21-028310","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2021-12-10T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Milestone director adopts 10b5-1 plan to sell ~$1M stock at $20k/week","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board member and former CEO Leonard Osser adopts Rule 10b5-1 trading plan effective December 13, 2021.","Plan to sell shares to restore approximately $1,000,000 at a rate of $20,000 per week.","Proceeds to cover exercise price, tax obligations from stock option exercises and stock compensation, and diversification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":435940,"accession_number":"0001437749-21-016286","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2021-07-02T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Milestone Scientific CFO Scott Kahn departs; search underway for replacement","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Scott Kahn and company mutually agreed to part ways effective July 2, 2021.","No interim CFO named; existing finance and accounting team deemed sufficient.","Executive search firm retained to identify a permanent CFO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}